
Eyewire News: The Podcast
105 episodes — Page 2 of 3
Special Report: TFOS DEWS III Leaders Discuss New DED Guidance
Aug 20, 202510 min
First Commerical Surgeries Performed with MacTel Therapy
Aug 13, 20258 min
Alcon Acquires Staar for $1.5 Billion
Aug 6, 202513 min
Tryptyr Now Available in US
Jul 30, 20254 min
Harrow Adds Biosimilars to US Portfolio
Jul 23, 20254 min
AECOS Presentation Summaries
Jul 16, 202510 min
Alcon Acquires LumiThera
Jul 9, 20256 min
Glaukos' MIGS Technology Certified in Europe; New Phase 3 Data for Presbyopia Drop
Jul 2, 20255 min
Special Report: Update on Holland Foundation
Jun 25, 20258 min
TFOS DEWS III Published
Jun 18, 20255 min
First Myopia Drug Approved in Europe
Jun 11, 20254 min
Alcon Gains FDA Approval for Novel DED Drug
Jun 4, 20258 min
Special Report: Executives Discuss Overcoming Challenges
May 28, 202521 min
B+L Launches New Scleral Lenses Technology
May 21, 20253 min
B+L Receives Approval in Europe for LuxLife IOL
May 14, 20255 min
Ophthalmic Leaders Launch SightLine Meeting
May 7, 20259 min
Breaking News from the ASCRS Meeting in Los Angeles
Apr 30, 202514 min
FDA Issues CRL to Regeneron for Eylea HD Extended Dosing
Apr 23, 20254 min
Orasis Launches Presbyopia Eye Drop Qlosi
Apr 16, 20259 min
Utilizing AI to Provide DR Screening to Underserved Communities
Apr 9, 202517 min
Alcon Launches PanOptix Pro in US
Apr 2, 20256 min
Alcon Announces Plans to Acquire Lensar
Mar 26, 20255 min
FDA Expands Product Label for Iluvien
Mar 19, 20254 min
FDA Approves First Treatment for MacTel
Mar 12, 20258 min
Haag-Streit Launches METIS 900 Microscope
Mar 5, 20254 min
New Myopia Software on Pentacam AXL
Feb 26, 20254 min
Alcon Voyager DSLT Fully Launched in US
Feb 19, 20256 min
AAO Opposes NIH Research Funding Proposal
Feb 12, 20255 min
FDA Approves Genentech's Susvimo Ocular Implant for DME
Feb 5, 20255 min
Norlase Launches First Pattern Scanning LIO
Jan 29, 20256 min
Zeiss MEL 90 Approved by FDA
Jan 22, 20255 min
Special Report – Increasing Access to Care Through the Cure Blindness Project
Jan 15, 20259 min
Glaukos Submits NDA for Epi-On CLX Candidate
Jan 8, 20255 min
2024 Year in Review — Part 2
Jan 1, 202512 min
2024 Year in Review — Part 1
Dec 25, 202411 min
B+L Bolsters Glaucoma Offerings with Elios Acquisition
Dec 18, 20244 min
Phase 3 Results for Novel Sedation Tablet
Dec 11, 20244 min
Phakic IOL for Presbyopia Approved in Europe
Dec 4, 20244 min
Special Report: OWL Celebrates 20th Anniversary
Nov 27, 20247 min
Lumithera CEO Discusses FDA Authorization for Veleda for Dry AMD
Nov 20, 202410 min
Ophthalmic Executives Provide Company Updates (Part 2 of 2)
Nov 13, 202415 min
Ophthalmic Executives Provide Company Updates (Part 1 of 2)
Nov 6, 202431 min
Posterior Segment Company Updates
Oct 30, 20247 min
Breaking News From the AAO Meeting in Chicago
Oct 23, 202413 min
B+L Receives FDA Approval for enVista Envy IOL
Oct 16, 20244 min
Aldeyra Resubmits NDA for DED Drug Reproxalap
Oct 9, 20244 min
Water-Free Ciclosporin-Based Eye Drop for DED Approved in Europe
Oct 2, 20244 min
Two Partnerships Formed to Advance Glaucoma Treatments
Sep 25, 20244 min
Breaking News From the ESCRS Congress in Barcelona (Part 2 of 2)
Sep 18, 202410 min
Breaking News From the ESCRS Congress in Barcelona (Part 1 of 2)
Sep 11, 202412 min